Literature DB >> 11399691

Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging.

G Cuttitta1, F Cibella, V Bellia, V Grassi, S Cossi, S Bucchieri, G Bonsignore.   

Abstract

STUDY
OBJECTIVE: We evaluated whether aging may produce changes in bronchial hyperresponsiveness, risk of enhanced bronchoconstriction, and changes of bronchoconstriction perception.
SETTING: Each subject underwent a methacholine bronchial challenge. Methacholine challenge was stopped when one of the following conditions occurred: (1) plateau of bronchoconstriction; (2) decrease of FEV(1) > 40%; (3) FEV(1) drop below 1 L; or (4) excessive respiratory discomfort. Methacholine dose-response curves were plotted both for FVC and FEV(1). The provocative dose of methacholine causing a 20% decrease in FEV(1) with respect to baseline (PD(20)) and the fall in FVC (DeltaFVC) at PD(20) were computed. The Borg scale was used for scoring the perception of respiratory discomfort. PATIENTS: We compared 17 young asthmatic patients (aged 22 to 45 years) with 17 older asthmatic patients (aged 63 to 78 years) selected on the basis of similar baseline pulmonary function and disease duration.
RESULTS: No significant between-group difference was found in PD(20) and in plateau development. Conversely, DeltaFVC was significantly higher in the older group (mean +/- SD, 15.5 +/- 3.9% vs 11.6 +/- 5.5% in younger patients). In addition, DeltaFVC showed a positive linear relationship with age (p = 0.0026). Elderly subjects were less aware of bronchoconstriction during the methacholine challenge (p = 0.04).
CONCLUSIONS: In elderly patients with asthma having comparable pulmonary function and disease duration, bronchial responsiveness is not different from that observed in younger asthmatic patients. Nevertheless, in such patients, an age-related tendency to an enhanced bronchoconstriction and a reduced perception of the degree of bronchoconstriction exist.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399691     DOI: 10.1378/chest.119.6.1685

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

Review 1.  Treating asthma in the older patient: is there a place for leukotriene modifiers?

Authors:  Mitchell H Grayson; Phillip E Korenblat
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Impact of Age and Sex on Response to Asthma Therapy.

Authors:  Ryan M Dunn; Erik Lehman; Vernon M Chinchilli; Richard J Martin; Homer A Boushey; Elliot Israel; Monica Kraft; Stephen C Lazarus; Robert F Lemanske; Njira L Lugogo; Stephen P Peters; Christine A Sorkness; Stanley Szefler; Michael E Wechsler
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

Review 3.  Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come.

Authors:  D G Chapman; C G Irvin
Journal:  Clin Exp Allergy       Date:  2015-04       Impact factor: 5.018

4.  An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.

Authors:  Gwen S Skloot; Paula J Busse; Sidney S Braman; Elizabeth J Kovacs; Anne E Dixon; Carlos A Vaz Fragoso; Nicola Scichilone; Y S Prakash; Christina M Pabelick; Sameer K Mathur; Nicola A Hanania; Wendy C Moore; Peter G Gibson; Susan Zieman; Betina B Ragless
Journal:  Ann Am Thorac Soc       Date:  2016-11

Review 5.  Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients.

Authors:  Hoang Kim Tu Trinh; Ga-Young Ban; Ji-Ho Lee; Hae-Sim Park
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 6.  Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-01       Impact factor: 6.053

Review 7.  Asthma Over the Age of 65: All's Well That Ends Well.

Authors:  Alan P Baptist; Paula J Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2018 May - Jun

Review 8.  Clinical implications of airway hyperresponsiveness in COPD.

Authors:  Nicola Scichilone; Salvatore Battaglia; Alba La Sala; Vincenzo Bellia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 9.  Complexities of diagnosis and treatment of allergic respiratory disease in the elderly.

Authors:  Paula J Busse; Kiran Kilaru
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 10.  Effect of aging on respiratory system physiology and immunology.

Authors:  Gulshan Sharma; James Goodwin
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.